Proscia

Real-world multimodal pathology data network for research

Proscia Aperture is a real-world data platform that provides access to AI-enriched tissue images, molecular, clinical, and genomic data derived from nearly 4,000 hospitals and clinics. It enables biomarker discovery, cohort feasibility modeling, and assay validation with de-identified patient populations across multiple cancer types including breast, colorectal, prostate, ovarian, lung, and skin cancer.

FDA-cleared digital pathology platform for primary clinical diagnosis

Concentriq AP-Dx is an FDA-cleared digital pathology platform for primary diagnosis in clinical labs. It provides intelligent case review with AI-powered features including automated worklists, stain ordering recommendations, integrated image analysis, and structured reporting. The platform supports 45+ scanners, 25+ image formats including DICOM, and integrates bidirectionally with Epic Beaker and most LIS systems.

Pathology AI platform for life sciences and drug development

Concentriq LS is a research-use platform designed for pharmaceutical companies and life sciences organizations. It supports biomarker discovery with frontier pathology models, clinical trial operations across global sites, and companion diagnostics development. The platform includes agentic biomarker discovery tools, real-world data access, and capabilities for assay validation and deployment.

Research-use digital pathology platform with AI capabilities

Concentriq AP is a research-use only (RUO) digital pathology platform built on the same technology as Concentriq AP-Dx. It features intelligent case review, AI-powered image analysis with 230+ interoperable AI apps from partners like Ibex, Mindpeak, Visiopharm, Aiforia, and Waiv. The platform includes automated worklists, stain ordering, biomarker scoring, and structured reporting capabilities.